Format

Send to

Choose Destination
J Res Pharm Pract. 2012 Oct;1(2):77-80. doi: 10.4103/2279-042X.108375.

The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study.

Author information

1
Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran ; Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran ; Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran.
2
Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran ; Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran.
3
Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
4
Cell and Molecular Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Abstract

OBJECTIVE:

Pseudocatalase/superoxide dismutase (PSD) is a topical gel considered having therapeutic effects in vitiligo. This study was designed to evaluate the efficacy of this combination in vitiligo.

METHODS:

This was a pilot randomized, double-blind, placebo-controlled trial on 46 symmetrical vitiligo lesions of limbs in 23 patients referring to dermatology clinics, Isfahan, Iran in 2010. Patients were received this formula or placebo gels for the right and left lesions. Lesion area and degree of pigmentation were assessed at baseline, 2, 4, and 6 months.

FINDINGS:

There were no significant changes in lesion area and perifollicular pigmentation in each group (P > 0.05).

CONCLUSION:

The results indicated no significant therapeutic effect for PSD in vitiligo.

KEYWORDS:

Pseudocatalase/superoxide dismutase; efficacy; vitiligo

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center